Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Open Clinical Investigation to Evaluate the Effectiveness and Safety of Wortie® Freeze Plus in the Treatment of Common Warts and Plantar Warts

NCT05115669 is registered in ClinicalTrials.gov with Karo Pharma AB as lead sponsor.

NCT NCT05115669
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05115669 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Open Clinical Investigation to Evaluate the Effectiveness and Safety of Wortie® Freeze Plus in the Treatment of Common Warts and Plantar Warts
Lead sponsor
Karo Pharma AB
Phase
Not applicable
Overall status
Completed
Start date
October 12, 2021
Completion date
May 1, 2022
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

common wart, plantar wart